Related Experiment Video
Updated: Oct 4, 2025

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
mRNA and protein of p33ING1 in normal and cancer tissues
Shuang Zhao1, Hua-Chuan Zheng1
1Department of Experimental Oncology, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Background:
Inhibitor growth protein 1 (ING1) is a tumor suppressor, and its down-regulation is involved in the progression and aggressive phenotypes of human malignancies through its interactions with the H3K4me3 and p53.
Methods:
We collected datasets to analyze the relationship between ING1b mRNA expression and accumulative survival rate, and carried out immunohistochemistry analyses to determine the expression profiles of the p33ING1 protein on the mouse, normal human, and human cancer tissue microarrays.
Results:
Compared with normal tissues, the ING1b mRNA was highly expressed in various types of cancer tissues, including, colorectal, lung, and breast cancers, and was positively correlated with the overall survival rate of gastric cancer patients. In mouse tissues, the subcellular location of p33ING1 was frequently nuclear; however, it was occasionally cytoplasmic or nucleocytoplasmic. There was a positive detection in the neuron body, a part of glial cells, the glandular epithelium of the stomach, intestines, breast, hepatocytes, heart, skeletal muscle cells, the bronchial and alveolar epithelium, and nephric tubules. In human tissues, the p33ING1 protein, apart from its cytoplasmic distribution, was distributed in the nuclei of the tongue, esophagus, stomach, intestine, lung, trachea, skin, appendix, cervix, endometrium, ovary, and breast. p33ING1 immunoreactivity was strongly detected in the stomach, trachea, skin, cervix, and breast, while it was weak in the other tissues. The positive rate of p33ING1 was 41.0% in the tested cancer entities (489/1,194). In general, p33ING1 expression was restricted to only the cytoplasm for all cancers, whereas it was found in the nucleus of renal clear cells, ovarian and colorectal cancers. Among them, p33ING1 was expressed in more than half of squamous cell carcinomas derived from the esophagus and cervix, while it was rarely expressed in hepatocellular (21.0%) and renal clear cell carcinoma (19.4%).
Conclusions:
The findings suggest that p33ING1 might be participated in the repair and regeneration of organs or tissues the repair and regeneration of organs or tissue, and the carcinogenesis of the highly proliferative epithelium.
Insights
Inhibitor of growth protein 1 (ING1) expression, particularly ING1b mRNA, is elevated in many cancers and correlates with better survival in gastric patients. The p33ING1 protein shows varied localization, suggesting roles in tissue repair and epithelial carcinogenesis.
Area of Science:
- Molecular oncology
- Cancer biology
- Tumor suppressor genes
Background:
- Inhibitor of growth protein 1 (ING1) acts as a tumor suppressor.
- ING1 down-regulation is linked to cancer progression and aggressiveness.
- ING1 interacts with H3K4me3 and p53, influencing cellular processes.
Purpose of the Study:
- To investigate the relationship between ING1b mRNA expression and patient survival rates.
- To determine the expression profiles and subcellular localization of the p33ING1 protein in various human and mouse tissues, including cancerous ones.
Main Methods:
- Analysis of ING1b mRNA expression datasets correlated with survival.
- Immunohistochemistry to assess p33ING1 protein expression in tissue microarrays.
- Examination of normal and cancerous tissues from mice and humans.
Main Results:
- ING1b mRNA was highly expressed in colorectal, lung, and breast cancers, correlating positively with survival in gastric cancer.
- p33ING1 protein localization was predominantly nuclear in mouse tissues but varied (nuclear, cytoplasmic, nucleocytoplasmic) in human tissues.
- p33ING1 was detected in various normal human tissues; its expression varied in cancer, with strong detection in stomach, trachea, skin, cervix, and breast. Overall positive rate was 41.0% in tested cancers.
Conclusions:
- p33ING1 may play a role in organ/tissue repair and regeneration.
- The protein is potentially involved in the carcinogenesis of highly proliferative epithelia.
- Expression patterns suggest context-dependent functions of p33ING1 in cancer.
Related Concept Videos
Abnormal Proliferation
MicroRNAs

